Myocardial viability: Myocardial scintigraphy for assessing;La viabilite myocardique: Etude de la viabilite par scintigraphie myocardique

Presse Medicale

Volumn 27, Issue 21, 1998, Pages 1043-1049

  Pezard Ph ^a   Jallet, P ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL VIABILITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART MUSCLE CELL; HEART SCINTISCANNING; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEART; HEART CONTRACTION; HEART INFARCTION; HUMAN; PATHOPHYSIOLOGY; REPERFUSION INJURY; SCINTISCANNING; STUNNED HEART MUSCLE;

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; THALLIUM;

FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032513843     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Gropler RJ Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose. J Nucl Cardiol 1994 ; 1:S4-14.
2. Perrone-Filardi P, Bacharach SL, Dilsizian V et al. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. J Am Coll Cardiol 1994 ; 23:608-16.
3. Gropler RJ, Geltman EM, Sampathkumarau KS et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992 ; 20:569-77.
4. Bonow RO, Dilsizian V. Thallium-201 for assessment of myocardial viability. Semin Nucl Med 1991 ; 21:230-7.
5. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent Thallium defects. J Am Coll Cardiol 1987 ; 10:557-67.
6. Gibson RS, Watson DD, Taylor GJ et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983 ; 1:804-15.
7. Kiat H, Berman DS, Maddahi J et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 1988 ; 12:1456-63.
8. Yang LD, Berman DS, Kiat H et al. The frequency of late reversibility in SPECT Thallium-201 stress-redistribution studies. J Am Coll Cardiol 1990 ; 15:334-40.
9. Budinger TF, Pohost GM. Indication for Thallium reinjection by 3 hour plasma levels. Circulation 1993 ; 88:abs. 2875.
10. Dilsizian V, Rocco TP, Fredman NMT, Leon MB, Bonow R. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990 ; 232:141-6.
11. Dilsizian V, Bonow RO. Differential uptake and apparent 201 Tl washout after thallium reinjection : options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Circulation 1992 ; 85:1032-8.
12. Galli M, Marcassa C. Thallium-201 redistribution after early reinjection in patients with severe stress perfusion defects and ventricular dysfunction. Am Heart J 1994 ; 128:41-52.
13. Van Eck-Smit BLF, van der Wall EE, Kuijper AFM, Zwinderman AH, Pauwels EKJ. Immediate thallium-201 reinjection following stress imaging: a time-saving approach for detection of myocardial viability. J Nucl Med 1993 ; 34:737-43.
14. Dilsizian V, Perrone-Filardi P, Arrighi J et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium: Comparison with metabolic activity by Positron Emission Tomography. Circulation 1993 ; 88:941-52.
15. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991 ; 32:1718-24.
16. Marzullo P, Parodi O, Reisenhofer B et al. Value of rest Thallium-201/Sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993 ; 71:166-72.
17. Perlmutter NS, Wilson RA, Angello DA, Palac RT, Lin J, Brown BG. Ribose facilitates thallium-201 redistribution in patients with coronary artery disease. J Nucl Med 1991 ; 32:193-200.
18. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzzi P. Effects of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994 ; 74:843-8.
19. Montalescot G, Faraggi M, Drobinski G et al. Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation 1992 ; 86:47-55.
20. Fragasso G, Chierchia S, Conversano A et al. Temporal dependence of residual tissue viability after myocardial infarction. A study based on positron emission tomography (abstract). Eur Heart J 1989 ; 10:52.
21. Leavitt JI, Better N, Tow DE, Rocco TP. Demonstration of viable, stunned myocardium with technetium-99m-Sestamibi. J Nucl Med 1994 ; 35:1805-7.
22. Liu P. Technetium-99m-Sestamibi : another window on myocardial viability ? (editorial) J Nucl Med 1991 ; 32:298-9.
23. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functionnal recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997 ; 30:1451-60.
24. Marie PY, Danchin N, Juilliere Y et al. Is exercice-redistribution SPECT Tl201 with rest-reinjection sufficient to assess myocardial viability after infarction ? A comparison using iodine 123 methylhexadecanoic add imaging. (abstract) Eur Heart J 1993 ; 13:S319.
25. Machecourt J, Fagret D, Cinotti L et al. What is more accurate for the assessment of myocardial viability after myocardial infarction ? 201 Tl ans fatty acids SPECT studies were compared with FDC-PET in 15 pts. Circulation 1992 ; 86:1-108.
26. Sloof GW, Visser FC, Bax JJ et al. Increased uptake of iodine-123-BMIPP in chronic ischemis heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med 1998 ; 39:255-60.
27. Martin WH, Delbeke D, Patton JA et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995 ; 36:988-95.
28. Chen EQ, MacIntyre WJ, Go RT et al. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET. J Nucl Med 1997 ; 38:582-6.
29. Bax JJ, Valkema R, Visser FC et al. FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo. Eur Heart J 1997 ; 18(Suppl) D: D124-9.
30. Bax JJ, Cornel JH, Visser FC et al. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol 1997 ; 30:377-83.